Ten-year Outcomes of a Phase III, Multicenter, Randomized Controlled Trial (SHIP0804) with Three-Month Neoadjuvant Androgen Deprivation Prior to 125I-Seed Transperineal Prostate Brachytherapy Followed by Nil Versus Nine-Month Adjuvant Hormonal Therapy in Patients with Intermediate-Risk Prostate Cancer
International Journal of Radiation OncologyBiologyPhysics（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined